← Deep analysesHome
mttssn research · Nordic Deep Dive
Alm. Brand (ALMB.CO)
Finans · Dansk skadeförsäkring (Alm. Brand) · LTM Q1 2026
Analysis date: 2026-06-15
Price at analysis: DKK 15.42
Method: borsdata_v1
Conviction: MEDIUM
HOLD
Conviction: MEDIUM
A Danish P&C insurer (enlarged by the Codan Denmark acquisition) earning an 11% ROE but trading at a high 1.86× book versus a Gordon-justified ~1.22× — fully valued, with Codan integration synergies the key swing factor. HOLD.
Return on Equity
9.9%
Cost of equity ~9.5%
Price / Book
1.81×
1.86× book; premium
Fair P/B (Gordon)
1.06×
(ROE−g)/(COE−g); g 3%
Price / Target
DKK 15 → DKK 14
-6% base; HOLD
Price / Earnings
18.2×
≈17.0× earnings
P / TBV
6.81×
Price / tangible book
Economic Profit
+DKK 237M
+DKK 364M; 11% ROE
Equity (book)
DKK 12.4B
P&C insurer equity
Thesis

Alm. Brand is a Danish non-life (P&C) insurer, substantially enlarged by the acquisition of Codan's Danish business, making it a leading Danish P&C player. It earns an ~11% return on equity, with the combined ratio and Codan integration synergies the key earnings drivers.

On the ROE/P-B frame the equity is fully valued — 1.86× book against a Gordon-justified ~1.22× (ROE 11%, COE ~9.5%, g 3%), at ~17× earnings. The premium prices successful Codan synergies and combined-ratio improvement; on current returns it is rich.

Valuation · residual income (equity frame) & scenarios

Gordon fair P/B = (11%−3%)/(9.5%−3%) ≈ 1.22×, versus the current 1.86× — i.e. the market prices Codan synergies lifting ROE/combined-ratio. Fully valued on current returns, with the synergy delivery the swing factor.

Base DKK 14.5 (−3%); bull DKK 18 (Codan synergies + combined-ratio improvement lift ROE); bear DKK 11 (underwriting deterioration, a catastrophe year, or synergy disappointment).

Market-implied ROE
14.7%
sustainable ROE the price already demands — vs 9.9% observed
Current → Fair P/B
1.81× → 1.06×
at a sustained 9.9% ROE, Ke 9.5%, g 3%
Excess-return premium
DKK 1 / sh
value above DKK 8.54 book from the +0.4pp ROE−Ke spread

The operating reverse-DCF (NOPAT / invested capital / WACC) does not apply to a balance-sheet business — leverage is the raw material and "net debt" is not meaningful. The equity is valued on residual income: book equity plus the present value of returns above the cost of equity, discounted at Ke; the single-stage lens is the Gordon fair price-to-book, (ROE−g)/(Ke−g). The market prices in a sustainable ROE of 14.7% vs 9.9% currently earned; at a sustained 9.9% ROE the warranted P/B is 1.06× (DKK 9/sh, -41%).

Scenario24m targetImpl. ROEUpsideProb.Driver
BullDKK 1817%+17%30%Codan synergies + combined-ratio improvement lift ROE
BaseDKK 1414%-6%45%Full: prices synergies/ROE uplift
BearDKK 1111%-29%25%Underwriting deterioration / catastrophe / synergy miss
Prob-weightedDKK 15-5%100%Scenario-weighted expected value

Sensitivity — fair value / share at Ke × ROE

Ke \ ROE10%14%18%22%26%30%34%
8.00%12192632394653
8.75%10162228344046
9.50% (base)9142025303541
10.25%8131822273237
11.00%7121620252933

Green = fair value above the current price of DKK 15.42. For a financial the surface is dominated by cost of equity and sustainable ROE — not unit growth.

Method & data. ROE 9.9% and book equity are observed (net income / total equity). Cost of equity 9.5% and terminal g 3% are assumptions, shown explicitly and overridable.

⤓ Download the full model (.xlsx) — formula-driven sheets; flex the blue input cells and the model cascades in Excel.

Key drivers

1. Leading Danish P&C

Scale in Danish non-life insurance post-Codan, with pricing/underwriting data advantages.

2. Codan synergies

Integration cost/revenue synergies are the core earnings-uplift driver — the bull case.

3. Combined-ratio improvement

Underwriting discipline driving a better combined ratio lifts ROE.

4. High dividend / capital return

P&C cash generation funds a high dividend (13% free-cash yield).

5. Local focus

A focused Danish franchise with disciplined underwriting.

Key risks
Conclusion

Alm. Brand is a leading Danish P&C insurer at a full 1.86× book, pricing Codan synergies and a combined-ratio improvement. HOLD, medium conviction; base target DKK 14.5 (−3%).

Synergy delivery and combined-ratio improvement are the upside; the rich valuation on current returns and underwriting/catastrophe risk are the cautions.

Footnote evidence & sources

Every adjustment traces to the cited note/page in the source filing — click to open it there. Source reports archived locally.

NOPAT adjustments: Not available from structured data

Company add-backs we reject: Not available without footnote extraction

Pages read — FY: — · Q: —  

Analysis history

How the mttssn view has evolved — each prior dated note is preserved.